Castleview Partners »

Veracyte shares owned by Castleview Partners

Quarter-by-quarter ownership of Veracyte (VCYT) shares owned by Castleview Partners from 13F filings

Historical chart of Castleview Partners investment in Veracyte

Tip: Access up to 7 years of quarterly data

All positions including Veracyte held by Castleview Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Veracyte by Castleview Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $87k 2.6k 34.04
2024-09-30 $87k 2.6k 34.04

More positions owned by Castleview Partners

Valued Advisers Tr Regan Fltg Rate (MBSF)
Apple (AAPL)
Amgen (AMGN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Amazon (AMZN)
Spdr Ser Tr Prtflo S&p500 Hi (SPYD)
Microsoft Corporation (MSFT)
Home Depot (HD)
Vaneck Etf Trust Clo Etf (CLOI)
Bristol Myers Squibb (BMY)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Vaneck Merk Gold Etf Gold Shs (OUNZ)
Proshares Tr Pshs Ultra Qqq (QLD)

View all positions for Castleview Partners

Top funds holding Veracyte

Vanguard Group
BlackRock
Artisan Partners Limited Partnership
ARK Investment Management
Wellington Management Company
Arrowpoint Asset Management
State Street Corporation
Dimensional Fund Advisors
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
FMR
Geode Capital Management
Goldman Sachs Group
Jennifer Ranahan
Nuveen Asset Management

View all funds holding Veracyte